Trial · NCT00829738
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Heartburn | 14 days | Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe |
| Primary | Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Eructation/Sour Eructation | 14 days | Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe |
| Primary | Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Painful Swallowing | 14 days | Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe |
| Primary | Assessment of Pantoprazole at Final Visit: Efficacy Regarding Reflux Symptoms | 14 days | Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory |
| Secondary | Functional Dyspepsia Symptoms: Assessment of the Severity of Upper Abdominal Pain | 14 days | Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe |
| Secondary | Functional Dyspepsia Symptoms: Assessment of the Severity of Sensation of Fullness | 14 days | Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe |
| Secondary | Functional Dyspepsia Symptoms: Assessment of the Severity of Nausea | 14 days | Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe |
| Secondary | Assessment of Pantoprazole at Final Visit: Efficacy Regarding Dyspeptic Symptoms | 14 days | Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory |
| Secondary | Irritable Bowel Syndrome: Assessment of the Severity of Lower Abdominal Pain | 14 days | Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe |
| Secondary | Irritable Bowel Syndrome: Assessment of the Severity of Diarrhoea | 14 days | Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe |
| Secondary | Irritable Bowel Syndrome: Assessment of the Severity of Constipation | 14 days | Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe |
| Secondary | Assessment of Pantoprazole at Final Visit: Efficacy Regarding Irritable Bowel Syndrome | 14 days | Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory |
| Secondary | Assessment of the Tolerability of Pantoprazole at Final Visit | 14 days | Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00829738/registered